ARTICLE | Clinical News
Latuda lurasidone regulatory update
November 5, 2012 8:00 AM UTC
FDA accepted for review 2 sNDAs from Dainippon's Sunovion Pharmaceuticals Inc. subsidiary for Latuda lurasidone to treat adult patients with depressive episodes associated with bipolar I disorder as a...